<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14773</id><no>EIP21-NFD-504</no><status>Open (affiliates only)</status><title>A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)</title><nct_id>NCT05869669</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><disease_site>Other</disease_site><PI>Torres-Yaghi, Yasar</PI><institution>Georgetown University Medical Center : Luke Lovelace</institution><management_group>GUMC Neurology; GUMC PFS</management_group><item><contact_id>10704</contact_id><item_description>Luke Lovelace</item_description><js_safe_str>Luke Lovelace</js_safe_str><email>ll928@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>